ELEDON PHARMACEUTICALS INC. - COMMON STOCK

Eledon Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 30, 2023

23 مارس 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon to Present Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation at the World Congress of Nephrology 2023

23 مارس 2023 08:00:02 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at SVB Securities Global Biopharma Conference

08 فبراير 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Provides Business and Pipeline Updates

09 يناير 2023 08:31:00 بحسب Nasdaq GlobeNewswire

C-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System

21 ديسمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results

14 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

03 نوفمبر 2022 16:05:01 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Upcoming Presentations at ASN’s Kidney Week 2022 and NEALS

24 أكتوبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in Two Upcoming Conferences

03 أكتوبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference

22 سبتمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy

06 سبتمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences

29 أغسطس 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results

11 أغسطس 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022

04 أغسطس 2022 16:05:03 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces the First Patient Dosed in Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation

18 يوليو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 يونيو 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Pancreatic Islet Cell Transplantation

09 يونيو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at the Jefferies Healthcare Conference

02 يونيو 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart Demonstrating Safety, Target Engagement, and Biomarker Response in Patients Living with Amyotrophic Lateral Sclerosis

31 مايو 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports First Quarter 2022 Operating and Financial Results

12 مايو 2022 16:01:00 بحسب Nasdaq GlobeNewswire